Valuation: Qinghai Pharmaceutical Group Limited

Market Cap 194M 24.7M 21.15M 19.79M 18.12M 34M 2.36B 34.45M 234M 91.2M 1.19B 92.73M 90.71M 3.93B P/E 2024
-2.61x
P/E 2025 -7.56x
Enterprise Value 97.48M 12.43M 10.65M 9.97M 9.12M 17.12M 1.19B 17.35M 118M 45.91M 598M 46.69M 45.67M 1.98B EV / Sales 2024
-0.1x
EV / Sales 2025 1.85x
Free-Float
40.37%
Yield 2024 *
-
Yield 2025 -
1 day+0.52%
1 week-13.12%
Current month+12.94%
1 month+11.63%
3 months-62.72%
6 months-80.70%
Current year-45.14%
1 week 1.89
Extreme 1.89
2.4
1 month 1.66
Extreme 1.655
3.01
Current year 1.36
Extreme 1.36
10.95
1 year 1.1
Extreme 1.1
10.95
3 years 0.65
Extreme 0.65
10.95
5 years 0.65
Extreme 0.65
15.75
10 years 0.65
Extreme 0.65
29.5
Manager TitleAgeSince
Chief Executive Officer 45 26/02/2019
President 36 18/07/2025
Chief Operating Officer 45 16/09/2015
Director TitleAgeSince
Chairman 45 02/12/2016
Director/Board Member 61 11/01/2017
Director/Board Member 62 05/03/2018
Date Insider Type Main position Quantity % Market Cap.
22/7/20 Other

Director

6,000,000 0.1190%
22/7/20 Other

Chief Executive Officer

40,000,000 0.7933%
22/7/20 Other

Director

6,000,000 0.1190%
Change 5-day change 1-year change 3-year change Capi.($)
+0.52%-13.12%+60.00%+42.22% 24.7M
-3.33%-9.31%-1.55%-29.41% 18.47B
+0.49%+1.50%+5.85%+4.90% 18.1B
-0.98%+1.41%-55.40%-49.04% 6.35B
+1.53%+2.93% - - 4.46B
+0.84%+0.50%-6.54%-3.38% 2B
-0.11%-3.71%+38.04%+48.29% 1.98B
-4.08%-4.75%-47.64%-56.21% 1.16B
+0.31%-0.72%+50.55%+190.46% 979M
+2.33%+2.45%+64.65%+237.40% 595M
Average -0.25%-1.59%+12.00%+42.80% 5.41B
Weighted average by Cap. -0.99%-2.43%-3.59%-8.33%

Financials

2024 2025
Net sales 185M 23.64M 20.25M 18.95M 17.35M 32.55M 2.26B 32.98M 224M 87.31M 1.14B 88.77M 86.84M 3.76B 139M 17.74M 15.2M 14.22M 13.02M 24.43M 1.7B 24.75M 168M 65.52M 853M 66.63M 65.18M 2.82B
Net income -46.36M -5.91M -5.06M -4.74M -4.34M -8.14M -566M -8.25M -55.99M -21.83M -284M -22.2M -21.72M -940M -46.68M -5.95M -5.1M -4.77M -4.37M -8.2M -570M -8.31M -56.38M -21.99M -286M -22.36M -21.87M -947M
Net Debt -139M -17.72M -15.18M -14.21M -13M -24.4M -1.7B -24.73M -168M -65.45M -852M -66.55M -65.11M -2.82B -96.14M -12.26M -10.5M -9.83M -9M -16.88M -1.17B -17.11M -116M -45.28M -589M -46.05M -45.04M -1.95B
Logo Qinghai Pharmaceutical Group Limited
Kaisa Health Group Holdings Ltd, formerly Mega Medical Technology Ltd, is an investment holding company principally engaged in the manufacture and sale of dental prosthetics. The Company operates its business through three segments. The Dental Prosthetics Business segment is engaged in the manufacture and sale of dental prosthetics. The Health Care Rehabilitation Business segment provides public health and medical services, including postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction and other rehabilitation services. The Health Care Health Leisure Business segment provides agricultural (cultural) tourism and construction of health care real estate projects.
Employees
825
Date Price Change Volume
21/08/26 HKD 1.920 +0.52% 2,000
20/08/26 HKD 1.910 -11.98% 60,000
19/08/26 HKD 2.170 +3.33% 8,000
18/08/26 HKD 2.100 0.00% 0
17/08/26 HKD 2.100 -4.98% 4,000